{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/rubella/diagnosis/clinical-features/","result":{"pageContext":{"chapter":{"id":"da084fad-aad1-57b0-8b1f-779333543cf7","slug":"clinical-features","fullItemName":"Clinical features","depth":2,"htmlHeader":"<!-- begin field e2714ed9-0166-4a73-bb1a-a99d00a8e40c --><h2>When should I suspect rubella?</h2><!-- end field e2714ed9-0166-4a73-bb1a-a99d00a8e40c -->","summary":"","htmlStringContent":"<!-- begin item 2d3aea49-5844-4e13-9550-a99d00a8e37f --><!-- begin field 7195564e-6691-4b80-a134-a99d00a8e40c --><ul><li><strong>There are no clinical features specific to rubella infection — diagnosis cannot be made on clinical features alone, laboratory confirmation is required.</strong><ul><li>Symptoms and signs of rubella infection are similar to many other conditions including other viral illnesses (such as parvovirus B19), toxoplasmosis, and allergic reactions. Rubella infection may be asymptomatic in up to 50% of people.</li></ul></li><li><strong>When present, clinical features develop 2–3 weeks after exposure and include:</strong><ul><li><strong>Rash</strong> — present in 50-80% of cases and typically starts on the face and neck before spreading down the body and becoming generalized. The rash is pink or light red, maculopapular and is transient (usually present for 3–5 days).</li><li><strong>Lymphadenopathy </strong>— may precede the rash and last for 2 weeks after the rash resolves. The suboccipital (lower part of the back of the skull), postauricular (behind the ears), and cervical (neck) lymph nodes are most often affected.</li><li><strong>Arthritis and arthralgia</strong> — arthralgia or arthritis is more common in adults and may occur in up to 70% of women with rubella.</li><li><strong>Non-specific symptoms</strong> tend to tend to affect adults more than children and in adults are sometimes prodromal — symptoms are significantly less severe than those associated with measles. They include low-grade fever (<39<sup>o</sup>C), headache, malaise, nausea, mild upper respiratory tract symptoms and non-purulent conjunctivitis.</li></ul></li><li><strong>Rubella should be suspected in people with clinical features consistent with infection or with risk factors:</strong><ul><li>It is essential to have a low threshold of suspicion for rubella in pregnant women, especially before 20 weeks' gestation. Rubella should be excluded even when <a class=\"topic-reference internal-reference\" href=\"/topics/rubella/diagnosis/differential-diagnosis/\">other causes</a> (such as measles, enterovirus, infectious mononucleosis, and streptococcal infection) are considered to be more likely — women who have not spent their childhood years in the UK may be at increased risk.</li><li>Risk factors include:<ul><li>Incomplete immunization and no evidence of previous infection. Rubella is unlikely in people who have previously had rubella (although reinfection can occur).</li><li>History of exposure to contacts with rubella within the last 3 weeks.</li><li>Travel to an area endemic for rubella.</li></ul></li></ul></li></ul><!-- end field 7195564e-6691-4b80-a134-a99d00a8e40c --><!-- end item 2d3aea49-5844-4e13-9550-a99d00a8e37f -->","topic":{"id":"f4a4135e-ffdc-5df5-b074-abfbec05f014","topicId":"300947fe-8e33-4d94-bbba-f4d16a0ba0f4","topicName":"Rubella","slug":"rubella","lastRevised":"Last revised in November 2018","chapters":[{"id":"3aff984b-cc64-5eef-a912-f7704fcdd2e0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"48701a5d-fb3c-54ae-8a4d-d8ffb0b3fd08","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9fe254c0-d336-5473-8be6-d3b58967643f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"783a0842-a9d9-5ecf-aa6d-183b6bd947f8","slug":"changes","fullItemName":"Changes"},{"id":"0b45633f-1453-5f54-bd26-a5d793bb79e0","slug":"update","fullItemName":"Update"}]},{"id":"4e272831-90b9-5f58-8133-46358fd68bc3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"71613e96-82dc-56c0-a022-916278e5d473","slug":"goals","fullItemName":"Goals"},{"id":"1b880ef4-fa9c-5899-a396-74128fb2bf51","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bebe0c0e-b00e-5e4f-a9f0-bf76dc254163","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"98a30d33-4581-55fa-93c7-c24d96973f5b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a3a2016b-1d86-5856-be17-747a8db43be0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6d487784-2b75-58e2-acd3-8542a361a149","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d0918936-370c-5c73-89bd-9f683169c2b7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"491f6f98-9648-5cc7-9db1-1e8547d3dc07","slug":"definition","fullItemName":"Definition"},{"id":"a56a3c8f-7763-5bac-b0c1-b0f8511b1c11","slug":"cause","fullItemName":"Cause"},{"id":"ec058aad-7d08-52ae-9477-590932a58a90","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0e581233-5a46-5f2e-9b25-a488f499812d","slug":"complications","fullItemName":"Complications"},{"id":"17cdeb34-85ba-5fcb-9f0d-d74a2a51bb20","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"34f907f8-e8f5-5d22-98eb-deba682bb047","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"da084fad-aad1-57b0-8b1f-779333543cf7","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9198e681-3b01-56a1-883b-f3798a6121b9","slug":"assessment","fullItemName":"Assessment"},{"id":"f9b81df6-547e-5760-9691-a9637efd7f52","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"349017cb-aa09-5c4f-9adb-c3cd0b689c57","fullItemName":"Management","slug":"management","subChapters":[{"id":"dff6856b-8ce5-59b8-911b-139c6149a61e","slug":"non-pregnant-suspected-rubella-or-possible-exposure","fullItemName":"Scenario: Non-pregnant - suspected rubella or possible exposure"},{"id":"ebcad003-eb41-5e51-b604-e5546e36c692","slug":"pregnant-suspected-confirmed-rubella-or-possible-exposure","fullItemName":"Scenario: Pregnant - suspected/confirmed rubella or possible exposure"}]},{"id":"3875c788-962e-5c7a-8996-f7f23d3d842d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"998db942-1480-55a2-b4c9-1e6857da624a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f2be8bd9-0794-52a8-a9f6-0dfa3d744111","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"670c60c7-d470-5310-9dfd-cd849cdb432d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a7436ace-aca6-5c90-9e7c-7b7a5f055024","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"741cd2cb-5dcf-5f25-bae1-8b35a0aa88ba","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b9d37643-879f-5874-a2e5-2eeda488084d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5e833736-5cb6-56ed-ac76-3dedea764334","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"34f907f8-e8f5-5d22-98eb-deba682bb047","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"4049cef5-aa5d-5d96-bc8a-b11f455b94e5","slug":"basis-for-recommendation-d81","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 9f26961a-723a-489e-8a92-a99d00a8fc09 --><h3>Basis for recommendation</h3><!-- end field 9f26961a-723a-489e-8a92-a99d00a8fc09 -->","summary":null,"htmlStringContent":"<!-- begin item d81d5ac2-d4bd-4dce-bead-a99d00a8fa4c --><!-- begin field 79ec987a-5b87-4be9-87e4-a99d00a8fc09 --><p>The information on the clinical features of rubella is based on clinical guidelines <em>Rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">HPA, 2011b</a>], Immunisation against infectious disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2013</a>], <em>Rubella (German measles): guidance, data and analysis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2016a</a>], <em>Rubella (German Measles, Three-Day Measles)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2017</a>], <em>Health protection in schools and other childcare facilities. A practical guide for staff on managing cases of infectious diseases in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2017</a>], <em>Rubella in Pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Dontigny, 2018</a>] and <em>Viral exanthems</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PCDS, 2018</a>], the World Health Organisation factsheet on <em>Rubella</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">WHO, 2018</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bouthry, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Young, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">BMJ Best Practice, 2018</a>].</p><h4>Clinical features are non-specific</h4><ul><li>Consensus opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Dontigny, 2018</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bouthry, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bukasa, 2018</a>] is that clinical diagnosis of rubella is unreliable as signs and symptoms of infection are non-speciﬁc — laboratory confirmation of infection is essential.</li></ul><h4>Immunity</h4><ul><li>Most people develop life-long immunity after an episode of rubella (either acquired naturally or through immunization) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Gershon, 2010</a>].</li><li>Rubella reinfection can occur in people who have rubella antibodies from previous natural rubella infection or rubella immunization. It is typically subclinical and difﬁcult to diagnose. Incidence of reinfection during pregnancy and the risk of transmission to the fetus is unclear. Some prospective studies suggest that risk of congenital rubella syndrome is likely to be less than 5% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bouthry, 2014</a>].</li><li>Immunization with one dose of the combined measles, mumps, and rubella (MMR) vaccine confers 95–100% protection against rubella. An additional dose, as indicated by the childhood immunization programme, provides close to full protection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2013</a>].</li></ul><!-- end field 79ec987a-5b87-4be9-87e4-a99d00a8fc09 --><!-- end item d81d5ac2-d4bd-4dce-bead-a99d00a8fa4c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}